GSA CAPITAL PARTNERS LLP - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 29 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2017. The put-call ratio across all filers is 6.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2020$47,000
-44.0%
18,912
-18.2%
0.01%
+60.0%
Q1 2017$84,000
-9.7%
23,107
-34.0%
0.01%
-16.7%
Q4 2016$93,000
-7.9%
35,007
+13.3%
0.01%
+20.0%
Q3 2016$101,000
+14.8%
30,907
+17.5%
0.01%0.0%
Q2 2016$88,000
-62.1%
26,307
-72.3%
0.01%
-66.7%
Q1 2016$232,00094,8940.02%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q1 2017
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$44,0000.03%
Brown Advisory Securities, LLC 28,000$35,0000.02%
Murchinson Ltd. 76,404$96,0000.02%
WEBSTER BANK, N. A. 80,000$101,0000.01%
Patriot Financial Group Insurance Agency, LLC 34,650$44,0000.01%
WMS Partners, LLC 42,000$53,0000.01%
Willow Creek Wealth Management Inc. 18,724$24,0000.01%
Cubic Asset Management, LLC 14,000$18,0000.00%
CVI Holdings, LLC 45,993$58,0000.00%
One Day In July LLC 10,000$13,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders